1. A retrospective cohort study on the effects of Down’s screening markers and maternal characteristics on pregnancy outcomes in preeclampsia
- Author
-
Bin Wu, Wenwen Ning, Yijie Chen, Caihe Wen, Huimin Zhang, and Yiming Chen
- Subjects
Fetal Growth Retardation ,Cesarean Section ,Physiology ,Pregnancy Outcome ,Hydronephrosis ,General Medicine ,Cicatrix ,Pregnancy Trimester, First ,Pre-Eclampsia ,Pregnancy ,Prenatal Diagnosis ,Internal Medicine ,Humans ,Pregnancy-Associated Plasma Protein-A ,Premature Birth ,Chorionic Gonadotropin, beta Subunit, Human ,Female ,Down Syndrome ,Biomarkers ,Retrospective Studies - Abstract
To investigate the effects of down's screening markers and maternal characteristics on preeclampsia (PE) pregnancy outcome during early and middle pregnancy.A retrospective study of a cohort of 246 PE and 18,709 No-PE pregnant women who participated in Down's screening during early and middle pregnancy was performed. Clinical data of pregnancy-related were collected. Multivariate binary logistic regression was used to analyze the adjusted odds ratio (aOR) and 95% confidence interval (CI) of Down's screening markers, maternal characteristics, pregnancy outcome, and other related variables, and to evaluate the influencing factors of each indicator on PE.Compared with the non-PE group, the concentration and median multiple (MoM) of pregnancy-associated plasma protein-A (PAPP-A) and free beta subunit of human chorionic gonadotropin (free β-hCG) in PE group were both lower (Decreased maternal serum PAPP-A level, increased free β-hCG, hyperlipemia, premature delivery, cesarean section, live birth, hydronephrosis, fetal growth retardation, low birth weight, and infection are risk factors for PE, while uterine scar and premature rupture of membrane are protective factors for PE.
- Published
- 2022
- Full Text
- View/download PDF